We are live on
!
Find out more
SRC
Sage Rhino Capital Portfolio holdings
AUM
$617M
1-Year Est. Return
28.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+28.74%
3 Year Est. Return
+86.8%
5 Year Est. Return
+76.14%
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$51.2M
(+20%)
Cap. Flow
+$40.8M
Cap. Flow
% of AUM
13.4%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
193
New
15
Increased
115
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
+$32.6M |
| 2 |
iShares Gold Trust
IAU
|
+$2.59M |
| 3 |
Palantir
PLTR
|
+$1.46M |
| 4 |
Morgan Stanley
MS
|
+$1.33M |
| 5 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$3.68M |
| 2 |
EV
Eaton Vance Corp.
EV
|
+$1.89M |
| 3 |
GUT
Gabelli Utility Trust
GUT
|
+$1.3M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.26M |
| 5 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.85% |
| 2 | Healthcare | 13.21% |
| 3 | Financials | 3.74% |
| 4 | Consumer Discretionary | 3.39% |
| 5 | Communication Services | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novartis
NVS
$297B
| $447K | 0.15% |
5,230
+171
| +3% | +$15.3K |
|
102
Workiva
WK
$3.54B
| $441K | 0.14% |
5,000
| – | – |
|
103
iShares Core US Aggregate Bond ETF
AGG
$138B
| $438K | 0.14% |
3,848
| – | – |
|
104
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $437K | 0.14% |
8,400
| – | – |
|
105
Qualcomm
QCOM
$176B
| $437K | 0.14% |
3,296
-157
| -5% | -$22.6K |
|
106
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
| $429K | 0.14% |
13,045
| – | – |
|
107
Schwab U.S Small- Cap ETF
SCHA
$23.1B
| $424K | 0.14% |
17,036
| – | – |
|
108
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $421K | 0.14% |
8,573
| – | – |
|
109
PayPal
PYPL
$50.5B
| $416K | 0.14% |
1,713
+431
| +34% | +$109K |
|
110
Costco
COST
$420B
| $415K | 0.14% |
1,178
-614
| -34% | -$214K |
|
|
SPLK
111
DELISTED
Splunk Inc
SPLK
| $407K | 0.13% |
3,006
| – | – |
|
112
Walt Disney
DIS
$181B
| $405K | 0.13% |
2,194
+67
| +3% | +$12.4K |
|
113
iShares MSCI Europe Financials ETF
EUFN
$4.29B
| $405K | 0.13% |
21,000
| – | – |
|
114
Toyota
TM
$225B
| $396K | 0.13% |
2,540
+22
| +0.9% | +$3.33K |
|
115
iShares Core S&P Small-Cap ETF
IJR
$112B
| $390K | 0.13% |
3,594
| – | – |
|
116
AstraZeneca
AZN
$250B
| $387K | 0.13% |
3,893
+74
| +2% | +$7.44K |
|
117
Carnival Corporation Ltd
CCL
$39.7B
| $387K | 0.13% |
14,597
+2,042
| +16% | +$48.2K |
|
118
Berkshire Hathaway Class A
BRK.A
$1.12T
| $386K | 0.13% |
+1
| New | +$367K |
|
|
CONE
119
DELISTED
CyrusOne Inc Common Stock
CONE
| $384K | 0.13% |
5,674
-10
| -0.2% | -$694 |
|
120
Eli Lilly
LLY
$1.06T
| $382K | 0.13% |
2,045
+29
| +1% | +$5.67K |
|
121
Phillips 66
PSX
$81.4B
| $368K | 0.12% |
4,514
+735
| +19% | +$57.7K |
|
122
Medtronic
MDT
$112B
| $366K | 0.12% |
3,097
+14
| +0.5% | +$1.64K |
|
123
NVIDIA
NVDA
$5.42T
| $364K | 0.12% |
27,240
+3,680
| +16% | +$49.5K |
|
124
Unilever
UL
$136B
| $355K | 0.12% |
5,649
+355
| +7% | +$22.6K |
|
125
Sony
SONY
$138B
| $345K | 0.11% |
16,265
+745
| +5% | +$15.7K |
|
Similar funds
VHMC
ACP
MC
TAM
AMG
KFAS
DTL
RC
Sage Rhino Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Sage Rhino Capital held 193 positions worth $304M, up 20% from $253M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Sage Rhino Capital deployed $40.8M of net new capital in Q1 2021, opening 15 new positions and adding to 115 existing holdings. Its largest new stake was Vincerx Pharma, Inc. Common Stock: 80,910 shares worth $31.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was DocuSign, an estimated $3.68M trimmed.
- Sage Rhino Capital's largest Q1 2021 buy was Vincerx Pharma, Inc. Common Stock: 80,910 shares worth $31.2M.
- Sage Rhino Capital added most to iShares Gold Trust in Q1 2021, an estimated $2.59M increase.
- Sage Rhino Capital's biggest Q1 2021 reduction was DocuSign, cutting an estimated $3.68M.
- Sage Rhino Capital fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $1.89M.
- Sage Rhino Capital's ten largest holdings make up 44% of its $304M portfolio in Q1 2021.
- Sage Rhino Capital opened 15 new positions and closed 8 in Q1 2021.
- Sage Rhino Capital's portfolio value rose 20% quarter-over-quarter to $304M.
Based on Sage Rhino Capital's 13F filing for Q1 2021, filed 4 May 2021.